Wuxi Biologics (Cayman) Inc. logo

Wuxi Biologics (Cayman) Inc. (2269)

Market Open
22 Jul, 08:00
HKEX HKEX
39. 86
HKD
+1.04
+2.679%
HKD
59.1B Market Cap
- P/E Ratio
- Div Yield
5.59M Volume
- Eps
38.82 HKD
Previous Close
Add Transaction
Day Range
38.5 40.1
Year Range
27.75 44
Want to track 2269 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Wuxi Biologics (Cayman) Inc. (2269) Statistics

Valuation metrics

Market Cap 59.1B
Enterprise value 126.14B
Trailing P/E (ttm) 26.82
Forward P/E -
PEG ratio 0.57
Price/Sales (ttm) 6.07
Price/Book (mrq) 2.85
Enterprise Value/Revenue 5.79
Enterprise Value/EBITDA 15.92

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 36.42M
Average volume (90 days) 29.37M

Price summary

52-Week low 27.75
52-Week high 44
Beta -
50-Day moving average 33.95
200-Day moving average 35.35

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 16 Nov 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.23%
Operating margin 0.3%

Operational effectiveness

Return on assets 0.08%
Return on equity 0.11%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 5.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.16
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 3.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 3.14%
Book value per share (mrq) 12.58

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -